NASDAQ:KITE (KITE) (KITE) Stock Price, News & Analysis → Why Is Gold On a MASSIVE rally? (From Huge Alerts) (Ad) Free KITE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$179.79▼$179.7950-Day Range N/A52-Week Range$39.82▼$179.99VolumeN/AAverage Volume1.65 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (KITE) alerts: Email Address Ad Huge AlertsWhy Is Gold On a MASSIVE rally? Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock.This Little known Company is a uniquely structured for profit About (KITE) Stock (NASDAQ:KITE)Kite Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products to target and kill cancer cells. The Company offers engineered autologous cell therapy, which is an approach to the treatment of cancer. Its therapy involves modifying a patient's T cells outside the patient's body, or ex vivo, causing the T cells to express chimeric antigen receptors (CARs), or T cell receptors (TCRs), and then reinfusing the engineered T cells back into the patient. Its lead product candidate, KTE-C19, is a CAR-based therapy that targets the CD19 antigen, a protein expressed on the cell surface of B-cell lymphomas and leukemias. The Company is conducting a registrational Phase II clinical trial (ZUMA-1) of KTE-C19 in patients with relapsed or refractory aggressive diffuse large B cell lymphoma (DLBCL), primary mediastinal B cell lymphoma (PMBCL), or transformed follicular lymphoma (TFL).Read More Ad Huge AlertsWhy Is Gold On a MASSIVE rally? Gold has been on a tear this year. The yellow metal has hit an all-time high of $2,4231.29 recently and the rally could be far from over. From central banks to even Costco customers, it seems everyone is buying gold these days. With Wall Street watching the gold space carefully, now is a perfect time to pay attention to this stock.This Little known Company is a uniquely structured for profit KITE Stock News HeadlinesMay 17 at 9:07 AM | msn.comZerodha Kite introduces 'Notes' for investors to track stocks. Check feature detailsMay 17 at 9:07 AM | nytimes.comHow Kite Surfing in Remote Colombia Changed a Boy. And a Village.May 16 at 8:37 PM | msn.comThings to do this weekend in San Diego: Asian Cultural Festival, Ocean Beach Kite Festival and moreMay 16 at 8:37 PM | msn.comElgin News Digest: Elgin Fire Department’s annual memorial service set for Saturday; South Elgin public works holding open house, selling rain barrels and compost bins ...May 16 at 10:36 AM | msn.comCrack Cloud Announce New Album ‘Red Mile’, Share New Single ‘Blue Kite’May 14 at 11:55 AM | msn.comZerodha brings new hands-on ‘notes’ feature for traders; How to use on Kite web? Here's a step-by-step guideMay 14 at 6:54 AM | msn.comKite Runner actor Bhavin Bhatt: ‘We delve into the mind of a sociopath’May 13, 2024 | yahoo.com‘Kite Runner’ in Charlotte for limited engagementMay 13, 2024 | msn.comFostering children: Tauranga’s Verna and George Kite recognised for five decades of careMay 10, 2024 | finance.yahoo.comKite and Arcellx prepare to launch Phase III multiple myeloma trialMay 9, 2024 | msn.comresult.kite.kerala.gov.in, dhsekerala.gov.in Result 2024 Declared: Official LINKS to Check Kerala DHSE Results Online with Registration Number, DOBMay 9, 2024 | msn.comdhsekerala.gov.in, result.kite.kerala.gov.in Result 2024: Official LINKS to Check Kerala DHSE Results Online with Registration Number, DOBMay 8, 2024 | msn.comKite Man Becomes Harley Quinns Nemesis in Amazing Looney Tunes TributeMay 8, 2024 | msn.comKerala SSLC Result 2024 Out: Kerala 10th Results declared at results.kite.kerala.gov.in; Here’s list of official websitesMay 8, 2024 | bbc.co.ukCatch A KiteMay 8, 2024 | msn.comresults.kite.kerala.gov.in, pareekshabhavan.kerala.gov.in Result 2024: Check Kerala SSLC Results Online with Roll Number, DOBMay 7, 2024 | msn.comKerala SSLC 10th Result 2024: Kerala 10th Result to be out soon at results.kite.kerala.gov- Know all details hereMay 5, 2024 | msn.comOcean Safety rescues 2 kite surfers separated them from kites after strong windsMay 5, 2024 | msn.comFree two-day kite festival to take to the skies in BridlingtonMay 3, 2024 | msn.comKite Day at Terhune Orchards and More Things To Do with Kids in New Jersey this WeekendMay 3, 2024 | msn.comLocals ‘gutted’ as much-loved kite festival cancelled after more than 30 yearsMay 2, 2024 | msn.com'The Kite Runner's' journey of redemption ends at MainStage ProctorsMay 1, 2024 | msn.com25th Annual Kite Festival to be held in Camp HillMay 1, 2024 | msn.comAnimal Welfare Board advises complete ban on 'manja' in all forms, asks to stick to only plain cotton thread for kite flyingApril 30, 2024 | msn.comKite festival cancelled after conservation concernsSee More Headlines Receive KITE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (KITE) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2017Today5/17/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:KITE CUSIPN/A CIK1510580 Webwww.kitepharma.com Phone+1-310-8249999FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableOptionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesArie S. BelldegrunExecutive Chairman of the Board, President, Chief Executive Officer, FounderPaul L. JenkinsonChief Financial OfficerCynthia M. ButittaChief Operating OfficerDavid Chang M.D. Ph.D.Executive Vice President - Research and Development, Chief Medical OfficerHelen S. KimExecutive Vice President - Business DevelopmentTimothy L. MooreExecutive Vice President - Technical OperationsChristine CassianoSenior Vice President - Corporate Communications and Investor RelationsBio & Compensation - Jian Irish Ph.D.Senior Vice President - Supply ChainBio & Compensation - Jeffrey Wiezorek M.D.Senior Vice President - Clinical DevelopmentShawn Cline TomaselloChief Commercial OfficerMore Executives KITE Stock Analysis - Frequently Asked Questions How were (KITE)'s earnings last quarter? (KITE) (NASDAQ:KITE) issued its quarterly earnings data on Tuesday, February, 28th. The biopharmaceutical company reported ($1.70) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.75) by $0.05. The biopharmaceutical company had revenue of $4.90 million for the quarter, compared to analysts' expectations of $5.74 million. The company's revenue for the quarter was up .0% on a year-over-year basis. During the same period in the previous year, the business posted ($0.54) earnings per share. What other stocks do shareholders of (KITE) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (KITE) investors own include Puma Biotechnology (PBYI), (MDVN) (MDVN), BioMarin Pharmaceutical (BMRN), Incyte (INCY), First Solar (FSLR), Dynavax Technologies (DVAX), United Airlines (UAL), Juno Therapeutics (JUNO), Array Technologies (ARRY) and bluebird bio (BLUE). This page (NASDAQ:KITE) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyDems have chosen Biden replacement?Paradigm PressHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge Alerts348 million Americans lives to END as we know it?The Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldThis is bad news for Biden…The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (KITE) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.